reference/33108633

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33108633

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase III\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	65
issn	0920-1211
pageRange	59-65
publicationName	Epilepsy Research
startingPage	59
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_46f29d21581aa7c5804b95f946e74541
bibliographicCitation	Chung S, Sinha SR, Shah A, Stern JM, Cheng H, Jung J, Grinnell T, Blum D. Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures. Epilepsy Res. 2019 Jul;153():59–65. doi: 10.1016/j.eplepsyres.2019.03.018. PMID: 30999260.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c61f869429dd74049ce45d7bcb1311ff http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-7370-3004 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4421def1761d69b2e7930b31062a2330 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0bd53662228bca0eb4838701569199c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5ce4ff55fcc11e539dc33465564bcaba http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1150-8331 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2990-2070 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bacb4b123582cbf567c81eb439c04e6e
date	201907
identifier	https://pubmed.ncbi.nlm.nih.gov/30999260 https://doi.org/10.1016/j.eplepsyres.2019.03.018
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3587 https://portal.issn.org/resource/ISSN/0920-1211
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Long-term safety and efficacy following conversion to eslicarbazepine acetate monotherapy in adults with focal seizures
discusses	http://id.nlm.nih.gov/mesh/M0006249 http://id.nlm.nih.gov/mesh/M0374531 http://id.nlm.nih.gov/mesh/M0001382
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D003984Q000627 http://id.nlm.nih.gov/mesh/D064420Q000209 http://id.nlm.nih.gov/mesh/D012640Q000188 http://id.nlm.nih.gov/mesh/D000927Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012640Q000523 http://id.nlm.nih.gov/mesh/D000293 http://id.nlm.nih.gov/mesh/D008137 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D011788 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D055815 http://id.nlm.nih.gov/mesh/D003863Q000209 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D003863Q000175 http://id.nlm.nih.gov/mesh/D012640Q000150 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000328
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9191 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7483 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8096 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7617 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7428 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8126 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8140 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID179344

Total number of triples: 56.